While we did not observe a difference in VEGFA levels between the DSG2‐high and DSG2‐low patients in the non‐MS cohort, other genes associated with tumour vascularization (e.g. SOX4 and SOX2 [32, 33]) were co‐expressed with DSG2. This evidence concerns the gene DSG2 and myeloid sarcoma.